THE HAZY, lazy days of summer are here. But at least in my part of the country, the weather has not heated up and neither have the biotech indices. If anything, they are heading south faster than geese after the first frost. What’s going on? Has biotech gone out of favor once again? No, I think what we are seeing is investor reaction to the FDA. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.